PRNFL as a marker of disability worsening in the medium/long term in patients with MS

Christian Cordano, Bardia Nourbakhsh, Michael Devereux, Vincent Damotte, Daniel Bennett, Stephen L. Hauser, Bruce A.C. Cree, Jeffrey M. Gelfand, Ari J. Green

Research output: Contribution to journalReview article

Original languageEnglish (US)
Article numbere533
JournalNeurology: Neuroimmunology and NeuroInflammation
Volume6
Issue number2
DOIs
StatePublished - Mar 1 2019

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Cordano, C., Nourbakhsh, B., Devereux, M., Damotte, V., Bennett, D., Hauser, S. L., Cree, B. A. C., Gelfand, J. M., & Green, A. J. (2019). PRNFL as a marker of disability worsening in the medium/long term in patients with MS. Neurology: Neuroimmunology and NeuroInflammation, 6(2), [e533]. https://doi.org/10.1212/NXI.0000000000000533